Document is current
Any future updates will be listed below
-
Authors
Eugeni, Patrick
Rooney, Megan E.
Saikali, Nicolas P.
Niu, Zhongzheng https://orcid.org/0000-0002-7168-8581
Driessen, Maurice T.
Krasenbaum, Lynda J.
Carr, Karen
Seminerio, Michael J.
McVige, Jennifer W.
-
Funding
Funding for this research was provided by:
Teva Pharmaceuticals (.)
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 31 October 2024
First Online: 8 January 2025
Declarations
:
: Patrick Eugeni, Megan E. Rooney, Nicolas P. Saikali, Zhongzheng Niu, and Jennifer W. McVige are employees of the Dent Neurological Institute, which performed this study funded by Teva Pharmaceuticals. Jennifer W. McVige has received research funding from AbbVie, Teva Pharmaceuticals, Eli Lilly, Amgen, and Lundbeck; and speaking/consulting fees from AbbVie, Teva Pharmaceuticals, Eli Lilly, Amgen, Lundbeck, Avanir, Theranica, and Amneal. Maurice T. Driessen and Lynda J. Krasenbaum are employees of Teva Pharmaceuticals. Karen Carr and Michael J. Seminerio are former employees of Teva Pharmaceuticals (current affiliation: AbbVie, North Chicago, IL, USA).
: As this was a retrospective database research using routine clinical practice data, a waiver of authorization for use and disclosure of protected health information (PHI) was granted by the WCG IRB on August 26, 2021. This study was in accordance with the Declaration of Helsinki.
